首页 | 官方网站   微博 | 高级检索  
     


Role of microRNA in regulation of myeloma-related angiogenesis and survival
Authors:Michal A Rahat  Meir Preis
Affiliation:Michal A Rahat, Immunology Research Unit, Carmel Medical Center, Haifa 3436212, IsraelMichal A Rahat, Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa 3109601, IsraelMeir Preis, Institute of Hematology, Carmel Medical Center, Haifa 3436212, Israel
Abstract:Multiple myeloma (MM) is a malignant disease caused by clonal proliferation of plasma cells that result in monoclonal gammopathy and severe end organ damage. Despite the uniform clinical signs, the disease is very diverse in terms of the nature and sequence of the underlying molecular events. Multiple cellular processes are involved in helping the malignant cells to remain viable and maintain proliferative properties in the hypoxic microenvironment of the bone marrow. Specifically, the process of angiogenesis, triggered by the interactions between the malignant MM cells and the stroma cells around them, was found to be critical for MM progression. In this review we highlight the current understanding about the epigenetic regulation of the proliferation and apoptosis of MM cells and its dependency on angiogenesis in the bone marrow that is carried out by different microRNAs.
Keywords:Multiple myeloma  MicroRNA  Angiogenesis  Proliferation  Apoptosis  Hypoxia  Vascular endothelial growth factor  Hypoxia-induce factor 1α  Macrophages  Endothelial cells
点击此处可从《World Journal of Hematology》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号